IP Library Granted Patent US 10,265,152
Granted Patent B2
US 10,265,152 · App. 13/652,145 · Granted Apr 23, 2019

Pelvic implant sizing systems and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,265,152
App. No.
13/652,145
Granted
Apr 23, 2019
Kind
B2
Abstract

Various embodiments of a mesh or implant sizing system are provided. An implant can include a gauging portion included with a support portion of the implant, to assist a surgeon in determining what size implant to insert into the pocket created in a tissue plane of the patient.

Claims (24)

1. An implant for treating pelvic prolapse in a patient, comprising:

a support portion including a plurality of undulating strut members to define a plurality of repeating cells having voids,

one or more anchoring portions in operative communication with the support portion; and

a gauging portion having a first flexible vertical strut element and a second vertical strut element, the second vertical strut element having a same opposing shape as the first vertical strut element, each of the first and second vertical strut elements includes two linear vertical sections and an arcuate section therebetween for each of the respective opposing strut elements, the arcuate sections facing each other and provided generally central along the respective opposing strut element, and a gap therebetween such that the arcuate sections are capable of moving toward and away from one another to provide an indication of whether an interior tissue pocket is acceptable to receive at least the support portion.

2. The implant of claim 1 , wherein the one or more anchoring portions includes four anchoring eyelets.

3. The implant of claim 1 , wherein the support portion is constructed as a unitary support portion wherein the plurality of undulating strut members are joined at and spanning out from a plurality of fixed junctions.

4. The implant of claim 1 , wherein at least the support portion is formed from a polymer molding process.

5. The implant of claim 1 , wherein the one or more anchoring portions includes one or more tissue anchors.

6. The implant of claim 1 , wherein the first and second flexible vertical strut elements create a void larger than the voids of the repeating cells.

7. The implant of claim 1 , wherein the gauging portion is defined in the support portion.

8. The implant of claim 1 , wherein the opposing strut elements of the gauging portion are generally thicker than the plurality of strut members of the support portion.

9. An implant kit for treating pelvic prolapse in a patient, comprising:

at least two implants, each of the at least two implants including:

a support portion having a plurality of strut members to define a plurality of void;

one or more anchoring portions in operative communication with the support portion; and

a gauging portion having first and second generally flexible opposing and vertically extending strut elements to define a pair of vertical linear portions and an arcuate portion therebetween for each of the respective opposing strut elements, the arcuate portions facing each other and provided generally longitudinally central along the respective opposing strut element, and a gap therebetween such that the arcuate portions are capable of moving toward one another to provide an indication of whether an interior tissue pocket is acceptable to receive at least the support portion, wherein the arcuate portions include a generally flat tab surface facing each other, wherein the opposing strut elements of the gauging portion are generally thinner than the plurality of strut members of the support portion.

10. The implant of claim 9 , wherein the one or more anchoring portions includes four anchoring eyelets.

11. The implant of claim 9 , wherein the support portion is constructed as a unitary support portion wherein the plurality of strut members are joined at and spanning out from a plurality of fixed junctions.

12. The implant of claim 9 , wherein at least the support portion is formed from a polymer molding process.

13. The implant of claim 9 , wherein the one or more anchoring portions includes one or more tissue anchors.

14. The implant of claim 9 , wherein the first and second generally flexible opposing strut elements create a void larger than the voids defined by the plurality of strut members.

15. The implant of claim 9 , wherein the gauging portion is defined in the support portion.

16. The implant of claim 9 , wherein the at least two implants includes at least a first small implant and a second large implant.

17. The implant of claim 9 , wherein the at least two implants are formed in a unitary homogeneous sheet or film.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: ASTORA WOMEN'S HEALTH, LLC; ENDO HEALTH SOLUTIONS INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043777/0895 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: BOSTON SCIENTIFIC CORPORATION
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 043778/0167 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA; PREVIOUSLY RECORDED ON REEL 037300 FRAME 0199. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Feb 25, 2016
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 037916/0028 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037473/0745 →
CHANGE OF NAME Recorded Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037473/0919 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0199 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2012
From: ARCAND, BENJAMIN Y.
To: AMS RESEARCH CORPORATION
Reel/Frame 029131/0189 →